Aurobindo Pharma launches COVID-19 drug Molnupiravir in India

Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, a press release from the city-based drug maker said. Molnupiravir was earlier approved under Emergency Use Authorisation from the Central Drugs Standard Control Organisation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3n1Hetw
via IFTTT